PUBLIC HEALTH INFORMATIONSecond French Study Suggests Malaria Drug Effective in Treating COVID-19 PatientsSaveMark Us Preferred on GooglePrintFrench professor Didier Raoult, director of IHU Mediterranee Infection Institute, in his office in Marseille, France, on March 23, 2020. Gerard Julien/AFP via Getty ImagesZachary StieberSenior Reporter3/28/2020|Updated: 4/10/2020A second French study of the malaria drug hydroxychloroquine suggests the drug is effective in treating COVID-19 patients, researchers said.The first study stoked controversy because it wasn’t peer-reviewed or published in a scientific journal. The second study is also preprint.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.